Weight Loss Intervention before Cord Blood Transplantation in an Obese Patient with Acute Myeloid Leukemia: A Case Study.
cord blood transplantation (CBT)
exercise
obesity
weight loss
Journal
Progress in rehabilitation medicine
ISSN: 2432-1354
Titre abrégé: Prog Rehabil Med
Pays: Japan
ID NLM: 101707740
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
12
2020
accepted:
04
03
2021
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
27
3
2021
Statut:
epublish
Résumé
A severely obese woman (39.8 kg/m During the salvage chemotherapy period, a 70-day weight loss program addressing diet and exercise was administered. After the 70-day intervention, the patient's body weight and body fat mass had decreased (8.6% and 15.0%, respectively) without any adverse events. The number of available cord blood units with total nucleated cells per body weight greater than 2 × 10 Considering this case, we suggest that a weight loss program combining exercise and nutrition therapy may help patients scheduled for hematopoietic stem cell transplantation by focusing on risk management.
Sections du résumé
BACKGROUND
BACKGROUND
A severely obese woman (39.8 kg/m
CASE
METHODS
During the salvage chemotherapy period, a 70-day weight loss program addressing diet and exercise was administered. After the 70-day intervention, the patient's body weight and body fat mass had decreased (8.6% and 15.0%, respectively) without any adverse events. The number of available cord blood units with total nucleated cells per body weight greater than 2 × 10
DISCUSSION
CONCLUSIONS
Considering this case, we suggest that a weight loss program combining exercise and nutrition therapy may help patients scheduled for hematopoietic stem cell transplantation by focusing on risk management.
Identifiants
pubmed: 33768187
doi: 10.2490/prm.20210018
pii: 20210018
pmc: PMC7972948
doi:
Types de publication
Case Reports
Langues
eng
Pagination
20210018Informations de copyright
©2021 The Japanese Association of Rehabilitation Medicine.
Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST: The authors declare that there are no conflicts of interest with any individuals or companies.
Références
Med Sci Sports Exerc. 2009 Feb;41(2):459-71
pubmed: 19127177
J Clin Oncol. 2007 May 1;25(13):1713-21
pubmed: 17470863
Bone Marrow Transplant. 2009 May;43(9):725-37
pubmed: 19234513
BMC Cancer. 2020 Nov 24;20(1):1142
pubmed: 33234112
J Clin Oncol. 2010 Jan 10;28(2):340-7
pubmed: 19949016
Bone Marrow Transplant. 2014 Dec;49(12):1505-12
pubmed: 25111511
Blood. 2011 Mar 3;117(9):2604-13
pubmed: 21190995
Bone Marrow Transplant. 2014 Jan;49(1):66-72
pubmed: 23955636
Biol Blood Marrow Transplant. 2017 Apr;23(4):659-669
pubmed: 28042020
J Clin Oncol. 2015 Jun 10;33(17):1918-27
pubmed: 25918291
J Int Soc Phys Rehabil Med. 2019 Jan-Mar;2(1):54-61
pubmed: 31131374